The information provided on Talecris Biotherapeutics albumin products is only intended for the United States audience.
Regulatory requirements, regulations, laws, and distribution of information about drug products may vary from country to country. Product names and indications (product uses) may also be different in other countries. The prescribing information provided here is based on United States labeling and may not be appropriate outside of the US.
The most current prescribing information is available for the following products:
 |
 |
Plasbumin®-5, Albumin (Human) 5%, USP (PDF) |
 |
Plasbumin®-5 (Low Aluminum), Albumin (Human) 5%, USP (PDF) |
 |
Plasbumin®-20, Albumin (Human) 20%, USP (PDF) |
 |
Plasbumin®-20 (Low Aluminum), Albumin (Human) 20%, USP (PDF) |
 |
Plasbumin®-25, Albumin (Human) 25%, USP (PDF) |
 |
Plasbumin®-25 (Low Aluminum), Albumin (Human) 25%, USP (PDF) |
 |
Plasmanate®, Plasma Protein Fraction (Human) 5%, USP (PDF) |
|
|